Active	Status	Sponsor type	Region	Phase	Filter
2 Active 7 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ruschitzka, Frank
DAPA-VOLVO, NCT04869124: Dapagliflozin on Volume Vascular Outcomes.	Completed	4	80	Europe	Dapagliflozin, Forxiga, Placebo	Frank Ruschitzka, AstraZeneca	Heart Failure，Congestive	09/24	10/24